Glycopyrrolate Injection
Product Images NDC 71288-414

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71288-414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Gly0a 0001 01)

Chemical structure of glycopyrrolate showing its molecular arrangement with a piperidinium ion and bromide counterion. The diagram depicts various functional groups, including hydroxyl, ester, and quaternary ammonium moieties consistent with the glycopyrrolate molecule.*

FDA Label Image

Figure (Gly0a 0001 02 V2)

Glycopyrrolate Injection, USP 0.2 mg/mL single-dose vial label by Meitheal Pharmaceuticals Inc. Indicates intramuscular or intravenous use, contains benzyl alcohol, and is made in China. Includes NDC 71288-414-01, barcode, lot, and expiration date fields.*

FDA Label Image

Figure (Gly0a 0001 03 V2)

Foldable carton label for Glycopyrrolate Injection, USP 0.2 mg per mL, a human prescription drug for intramuscular or intravenous use by Meitheal Pharmaceuticals Inc. The label indicates a package of 25 single-dose 1 mL vials, highlights that it contains benzyl alcohol, and includes storage instructions and barcodes.*

FDA Label Image

Figure (Gly0a 0001 04 V2)

Glycopyrrolate Injection, USP label showing a strength of 0.4 mg per 2 mL (0.2 mg per mL) in a single-dose vial. The label indicates it contains benzyl alcohol and is for intramuscular or intravenous use. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL, made in China. Includes NDC 71288-414-02 and space for lot and expiration dates.*

FDA Label Image

Figure (Gly0a 0001 05 V2)

Packaging label for Glycopyrrolate Injection, USP, 0.4 mg per 2 mL (0.2 mg per mL) by Meitheal Pharmaceuticals Inc. The label includes strength, dosage form, route of administration (intramuscular or intravenous), a warning 'Not for use in newborns,' and states it contains benzyl alcohol. The package contains 25 single-dose vials of 2 mL each.*

FDA Label Image

Figure (Gly0a 0001 06 V2)

Label for Glycopyrrolate Injection USP, 0.2 mg/mL (1 mg per 5 mL) in a 5 mL multi-dose vial. The label indicates use for intramuscular or intravenous administration, contains benzyl alcohol preservative, and notes it is not for use in newborns. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL, and made in China.*

FDA Label Image

Figure (Gly0a 0001 07 V2)

Packaging label for Glycopyrrolate Injection, USP by Meitheal Pharmaceuticals Inc. It contains 1 mg per 5 mL (0.2 mg per mL) strength in 25 multi-dose vials of 5 mL each. The label states it is for intramuscular or intravenous use and warns it is not for use in newborns. Contains benzyl alcohol as a preservative.*

FDA Label Image

Figure (Gly0a 0001 08 V2)

Label for Glycopyrrolate Injection, USP, 4 mg per 20 mL (0.2 mg per mL) multi-dose vial by Meitheal Pharmaceuticals Inc. The label states it contains benzyl alcohol and is for intramuscular or intravenous use, not for newborns. Storage instructions specify 20° to 25°C, with the preservative and pH adjustment details included.*

FDA Label Image

Principal Display Panel – Glycopyrrolate Injection, Usp 20 mL Carton (Gly0a 0001 09 V2)

Glycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg per mL) multi-dose vial packaging label from Meitheal Pharmaceuticals Inc. The label indicates it contains benzyl alcohol and is for intramuscular or intravenous use, with storage instructions and manufacturer information included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.